CAPR·14070B309·US·equity·Healthcare - Biotechnology-13D/G
CAPR (CAPRICOR THERAPEUTICS INC) is held by 99 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($104M), STATE STREET CORP ($66.3M), RA CAPITAL MANAGEMENT, L.P. ($45.8M). Net institutional sentiment: Bullish.
See how CAPR's score breaks down across 4 SEC sources
Showing 1-20 of 107
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer